- Home
- Companies
- Alafair Biosciences, Inc.
- Articles
- Pre-Clinical Effectiveness - Case Study
Pre-Clinical Effectiveness - Case Study
Courtesy of Alafair Biosciences, Inc.
VersaWrap as a Protective Interface
Background: Fibrous scar tissue between tendon and the surrounding tissue is a common complication following flexor tendon repair. Several factors contribute to scar tissue formation, including damage to the tendon sheath, suture placement, and tendon immobilization. Scar tissue formation results in increased work of flexion (WOF) and contracture formation, reducing the function of the digit.
-
Most popular related searches
Customer comments
No comments were found for Pre-Clinical Effectiveness - Case Study. Be the first to comment!